Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

23.40
Delayed Data
As of Jul 31
 +0.78 / +3.45%
Today’s Change
11.71
Today|||52-Week Range
30.37
+15.90%
Year-to-Date
No recent news for Flexion Therapeutics Inc.

Today’s Trading

Previous close22.62
Today’s open22.61
Day’s range22.22 - 23.85
Volume133,797
Average volume (3 months)153,387
Market cap$502.2M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+91.44%
Earnings growth (this year)-9.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.46

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...+2.11+3.17%
AMRNAmarin Corporation P...+0.06+2.73%
NVIVInVivo Therapeutics ...+0.34+2.39%
ONTYOncothyreon Inc+0.14+4.00%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$27.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Chief Financial Officer
Frederick W. Driscoll
Corporate headquarters
Burlington, Massachusetts

Forecasts